BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23586898)

  • 1. Aberrant microRNA expression in multiple myeloma.
    Dimopoulos K; Gimsing P; Grønbæk K
    Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.
    Yyusnita ; Norsiah ; Zakiah I; Chang KM; Purushotaman VS; Zubaidah Z; Jamal R
    Malays J Pathol; 2012 Dec; 34(2):133-43. PubMed ID: 23424776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation of microRNA genes in multiple myeloma.
    Wong KY; Huang X; Chim CS
    Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
    Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA deregulation in multiple myeloma.
    Bi CL; Chng WJ
    Chin Med J (Engl); 2011 Oct; 124(19):3164-9. PubMed ID: 22040573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of circulating miRNAs in multiple myeloma.
    Zhang J; Xiao X; Liu J
    Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of miRNAs as biomarkers for multiple myeloma.
    Rocci A; Hofmeister CC; Pichiorri F
    Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
    Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
    J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
    Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
    Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma].
    Handa H
    Rinsho Ketsueki; 2015 Aug; 56(8):981-8. PubMed ID: 26345556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Analysis of microRNA in Multiple Myeloma.
    Di Martino MT; Amodio N; Tassone P; Tagliaferri P
    Methods Mol Biol; 2016; 1375():181-94. PubMed ID: 25971914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.
    Wong KY; Chim CS
    Epigenomics; 2015; 7(6):985-1001. PubMed ID: 26417914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression.
    Seckinger A; Meißner T; Moreaux J; Benes V; Hillengass J; Castoldi M; Zimmermann J; Ho AD; Jauch A; Goldschmidt H; Klein B; Hose D
    Oncotarget; 2015 Nov; 6(36):39165-83. PubMed ID: 26472281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.
    Gutiérrez NC; Sarasquete ME; Misiewicz-Krzeminska I; Delgado M; De Las Rivas J; Ticona FV; Fermiñán E; Martín-Jiménez P; Chillón C; Risueño A; Hernández JM; García-Sanz R; González M; San Miguel JF
    Leukemia; 2010 Mar; 24(3):629-37. PubMed ID: 20054351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
    Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
    J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.